The clinical trials of Covid-19 vaccine — Covaxin — will begin at All India Institute of Medical Sciences (AIIMS)- Patna on July 10.
AIIMS-Patna is among the 12 medical institutes selected by the Indian Council for Medical Research (ICMR) for conducting human trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine).
AIIMS-Patna Superintendant Dr CM Singh said that the clinical trials of the country’s first indigenous COVID-19 vaccine would start in the next two days.
He said that the clinical vaccine trials will be initially carried out on 100 people registered for the purpose.AIIMS Patna has formed a team of doctors for the human trial of the vaccine jointly developed by the National Institute of Virology-Pune and Hyderabad-based Bharat Biotech International Limited (BBIL) in collaboration with the Indian Council of Medical Research (ICMR).
The ICMR has selected AIIMS-Patna among 12 institutes in the country for the clinical trials of the indigenous BBV152 Covid vaccine.
The vaccine trials would be done on only healthy people in the age group of 22-50 years, irrespective of gender. The ICMR would approve the vaccine for general use depending on the trials outcome, he said.
